Company Filing History:
Years Active: 2010
Title: Inventor Rajib Barik: Pioneering Pyrimidine Carboxamides in Tamil Nadu
Introduction: Rajib Barik, an innovative inventor based in Tamil Nadu, India, has made significant contributions to the field of medicinal chemistry. His work focuses on the development of novel compounds that can address a wide range of health issues, showcasing his expertise in synthetic organic chemistry and pharmaceutical applications.
Latest Patents: Rajib Barik holds a patent for "Pyrimidine Carboxamides," which pertains to a series of novel compounds characterized by the general formula (I). This invention encompasses not only the primary compounds but also their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, metabolites, and prodrugs. The patent outlines methods aiming for prophylaxis or treatment of various medical conditions such as pain disorders, immunological diseases, inflammation, rheumatoid arthritis, cancer, and more, highlighting the broad therapeutic potential of his work.
Career Highlights: Rajib Barik currently works for Orchid Research Laboratories Limited, a prominent organization dedicated to drug discovery and development. His role involves conducting research that contributes to the advancement of pharmaceutical science, particularly through the synthesis of novel compounds that can offer new treatment options for serious health conditions.
Collaborations: During his journey as an inventor, Rajib has collaborated with several esteemed colleagues, including Ravikumar Tadipartiii and Venkatesan Parameswaran. Together, they leverage their collective expertise to push the boundaries of research and innovation within the pharmaceutical industry.
Conclusion: Rajib Barik's innovative spirit and dedication to advancing medicinal chemistry have resulted in valuable contributions to health science. His patent on pyrimidine carboxamides exemplifies the kind of groundbreaking work taking place in Tamil Nadu and the potential it holds for improving health outcomes on a global scale. With ongoing collaborations and a commitment to research, Barik continues to be a driving force in the field of pharmaceutical innovation.